Biocon is reducing its workforce as it finalizes the integration of its biologics and generics businesses, impacting hundreds ...

Biocon's Siddharth Mittal steps down as MD & CEO; Shreehas Tambe, a 30-year company veteran with 61 patents, takes over from ...

Tambe, a nearly three‑decade Biocon veteran, will be the first CEO to lead the unified platform after Biocon Biologics was ...

Biocon Limited has appointed Shreehas Tambe as its Chief Executive Officer and Managing Director, effective April 1, 2026, as ...

Bengaluru: As Biocon prepares for a leadership transition on April 1, newly designated CEO and MD Shreehas Tambe has outlined ...

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars ...

Biocon share price has rallied over 20% in one month and has gained 17% in three months. The stock has surged 28% in six ...

Biocon Limited (BSE: 532523; NSE: BIOCON) today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1, 2026, following approvals from the ...

BENGALURU, India and BRIDGEWATER, N.J., Oct. 1, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON) ...

BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and ...

Biocon Biologics and Civica announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States. Under the terms of the agreement, Biocon Biologics ...

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...